[Hematopoietic stem cell transplantation ocular complications: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. / Prise en charge des complications ophtalmologiques de l'allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).
Bull Cancer
; 107(12S): S116-S121, 2020 Dec.
Article
en Fr
| MEDLINE
| ID: mdl-32631612
ABSTRACT
INTRODUCTION:
Allogeneic stem cell transplantation is currently the only curative therapy for hematological disorders. This treatment can lead to complications, of which ophtalmological involvement.METHODS:
We reviewed the literature and established accessible and convenient recommendations for hematologists and ophthalmologists.RESULTS:
Ophtalmological follow-up should be done in every patient having had an allogeneic transplantation, by the hematologist questioning and by the ophthalmologist physical exam. Complications due to graft-versus-host disease (GVHD) or not due to GVHD are cited, as well as therapeutic options.DISCUSSION:
Screening and treatment of ophthalmologic complications in allogeneic stem cells transplantation recipients requires a close collaboration between hematologists and ophthalmologists. The management of these patients by caregivers trained in these questions is encouraged.Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Trasplante de Células Madre Hematopoyéticas
/
Oftalmopatías
Tipo de estudio:
Diagnostic_studies
/
Guideline
Límite:
Humans
Idioma:
Fr
Revista:
Bull Cancer
Año:
2020
Tipo del documento:
Article